Experimental Immunotherapy Cures 3-Year-Old Boy’s Cancer
An experimental CAR T-cell therapy has driven advanced, chemotherapy-resistant liver cancer into a durable complete remission in a 3-year-old boy, according to a medical report published in the New England Journal of Medicine. The toddler, treated through an ongoing phase 1 trial at Baylor College of Medicine and Texas Children’s Hospital, remains cancer-free a year … Read more